Browsing by Author "He, Jie"

Now showing 1 - 2 of 2
  • Thumbnail Image
    Item
    Health Impairments in Children and Adolescents After Hospitalization for Acute COVID-19 or MIS-C
    (American Academy of Pediatrics, 2022) Maddux, Aline B.; Berbert, Laura; Young, Cameron C.; Feldstein, Leora R.; Zambrano, Laura D.; Kucukak, Suden; Newhams, Margaret M.; Miller, Kristen; FitzGerald, Madyson M.; He, Jie; Halasa, Natasha B.; Cvijanovich, Natalie Z.; Loftis, Laura L.; Walker, Tracie C.; Schwartz, Stephanie P.; Gertz, Shira J.; Tarquinio, Keiko M.; Fitzgerald, Julie C.; Kong, Michele; Schuster, Jennifer E.; Mack, Elizabeth H.; Hobbs, Charlotte V.; Rowan, Courtney M.; Staat, Mary A.; Zinter, Matt S.; Irby, Katherine; Crandall, Hillary; Flori, Heidi; Cullimore, Melissa L.; Nofziger, Ryan A.; Shein, Steven L.; Glas Gaspers, Mary; Hume, Janet R.; Levy, Emily R.; Chen, Sabrina R.; Patel, Manish M.; Tenforde, Mark W.; Weller, Edie; Campbell, Angela P.; Randolph, Adrienne G.; Overcoming COVID-19 Investigators; Pediatrics, School of Medicine
    Objectives: To evaluate risk factors for postdischarge sequelae in children and adolescents hospitalized for acute coronavirus disease 2019 (COVID-19) or multisystem inflammatory syndrome in children (MIS-C). Methods: Multicenter prospective cohort study conducted in 25 United States pediatric hospitals. Patients <21-years-old, hospitalized May 2020 to May 2021 for acute COVID-19 or MIS-C with follow-up 2 to 4 months after admission. We assessed readmissions, persistent symptoms or activity impairment, and new morbidities. Multivariable regression was used to calculate adjusted risk ratios (aRR) and 95% confidence intervals (CI). Results: Of 358 eligible patients, 2 to 4 month survey data were available for 119 of 155 (76.8%) with acute COVID-19 and 160 of 203 (78.8%) with MIS-C. Thirteen (11%) patients with acute COVID-19 and 12 (8%) with MIS-C had a readmission. Thirty-two (26.9%) patients with acute COVID-19 had persistent symptoms (22.7%) or activity impairment (14.3%) and 48 (30.0%) with MIS-C had persistent symptoms (20.0%) or activity impairment (21.3%). For patients with acute COVID-19, persistent symptoms (aRR, 1.29 [95% CI, 1.04-1.59]) and activity impairment (aRR, 1.37 [95% CI, 1.06-1.78]) were associated with more organ systems involved. Patients with MIS-C and pre-existing respiratory conditions more frequently had persistent symptoms (aRR, 3.09 [95% CI, 1.55-6.14]) and those with obesity more frequently had activity impairment (aRR, 2.52 [95% CI, 1.35-4.69]). New morbidities were infrequent (9% COVID-19, 1% MIS-C). Conclusions: Over 1 in 4 children hospitalized with acute COVID-19 or MIS-C experienced persistent symptoms or activity impairment for at least 2 months. Patients with MIS-C and respiratory conditions or obesity are at higher risk of prolonged recovery.
  • Thumbnail Image
    Item
    Society for Translational Medicine Expert consensus on the selection of surgical approaches in the management of thoracic esophageal carcinoma
    (AME Publishing Company, 2019-01) Mao, Yousheng; Yu, Zhentao; You, Bin; Fang, Wentao; Badgwell, Brian; Berry, Mark F.; Ceppa, DuyKhanh P.; Chen, Chun; Chen, Haiquan; Cuesta, Miguel A.; D’Journo, Xavier Benoit; Eslick, Guy D.; Fu, Jianhua; Fu, Xiangning; Gao, Shugeng; He, Jianxing; He, Jie; Huang, Yunchao; Jiang, Gening; Jiang, Zhongmin; Kim, Jae Y.; Li, Danqing; Li, Hui; Li, Shanqing; Liu, Deruo; Liu, Lunxu; Liu, Yongyu; Li, Xiaofei; Li, Yin; Mao, Weimin; Molena, Daniela; Morse, Christopher R.; Novoa, Nuria M.; Tan, Lijie; Tan, Qunyou; Toker, Alper; Tong, Ti; Wang, Qun; Weksler, Benny; Xu, Lin; Xu, Shidong; Yan, Tiansheng; Zhang, Lanjun; Zhang, Xingyi; Zhang, Xun; Zhang, Zhu; Zhi, Xiuyi; Zhou, Qinghua; Department of Surgery, Indiana University School of Medicine